Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40015893
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
23/11/2023
Statut
Classification
1.5°C
Année cible
2030
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target IQVIA commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets IQVIA commits to reduce absolute scope 1 and 2 GHG emissions 55.1% by 2030 from a 2019 base year.* IQVIA also commits to reduce absolute scope 3 GHG emissions from business travel 55% per FTE within the same timeframe. IQVIA further commits that 70% of its suppliers by emissions, covering purchased goods and services, capital goods, and upstream transport and distribution, will have science-based targets by 2027. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks. Long-Term Targets IQVIA commits to reduce absolute scope 1,2 and 3 GHG emissions 90% by 2050 from a 2019 base year.* *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
US46266C1053
LEI
549300W3R20NM4KQPH86
Source : Science Based Targets initiative | Données publiques